Stocktoria
Immix Biopharma, Inc. IMMX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-12-16
Immix Biopharma, Inc. statistics & valuation
Market cap$710.5M
P / B7.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -28.0% | -94.2% | -77.4% | -55.2% | -134.0% |
| Return on equity | -31.3% | -163.1% | -94.0% | -62.5% | -135.5% |
| Current ratio | 10.01 | 2.33 | 5.32 | 11.70 | 90.01 |
Source: SEC EDGAR filings · CIK 0001873835 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.